World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
61
Citations
11842
World Ranking
3259
National Ranking
146

Jacques Bienvenu publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jacques Bienvenu sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 197 publications — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jacques Bienvenu D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jacques Bienvenu sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 61 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jacques Bienvenu is affiliated with Claude Bernard University Lyon 1 in France. Their primary field of study is Medicine, with a focused subfield specialization in Immunology and Allergy. Additional subfields include Dermatology, Physiology, Surgery, and Genetics.

The research topics covered by Jacques Bienvenu span several areas within clinical immunology and allergy, specifically:

  • Allergic Rhinitis and Sensitization
  • Food Allergy and Anaphylaxis Research
  • Contact Dermatitis and Allergies
  • Asthma and respiratory diseases
  • Eosinophilic Esophagitis
  • Inflammatory Bowel Disease
  • Microscopic Colitis

Jacques Bienvenu has contributed to multiple papers, particularly focusing on allergy diagnosis and biological testing in France. Notable recent publications include:

  • "Recommandations pour la prescription et l'interprétation des examens biologiques utilisables dans le cadre du diagnostic ou du suivi des allergies, disponibles en France. Texte court" (2021) in Revue française d'allergologie
  • "Recommandations pour la prescription et l'interprétation des examens biologiques utilisables dans le cadre du diagnostic ou du suivi des allergies, disponibles en France. Partie 1: préambule" (2021) in Revue française d'allergologie
  • "Recommandations pour la prescription et l'interprétation des examens biologiques utilisables dans le cadre du diagnostic ou du suivi des allergies, disponibles en France. Partie 3: allergie alimentaire" (2021) in Revue française d'allergologie
  • "Nouvelles recommandations françaises en biologie de l'allergie, synthèse" (2020) in Revue française d'allergologie
  • "Relationships of circulating CD4+ T cell subsets and cytokines with the risk of relapse in patients with Crohn's disease" (2022) in Frontiers in Immunology

Frequent co-authors collaborating with Jacques Bienvenu include:

  • H. Chabane
  • A. Sarrat
  • E. Sève
  • G. Dalampira
  • C. Palussière

The scientist's research findings are commonly published in venues such as:

  • Revue française d'allergologie
  • Frontiers in Immunology
  • Transfusion Medicine Reviews

Best Publications

  • TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway

    Sébastien Viel;Antoine Marçais;Fernando Souza Fonseca Guimaraes;Fernando Souza Fonseca Guimaraes;Roisin Loftus

  • Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock

    Guillaume Monneret;Alain Lepape;Nicolas Voirin;Julien Bohé

  • The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells

    Antoine Marçais;Julien Cherfils-Vicini;Charlotte Viant;Sophie Degouve

  • T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow

    Cécile Daussy;Fabrice Faure;Katia Mayol;Sébastien Viel

  • Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis.

    Guillaume Monneret;Anne-Lise Debard;Fabienne Venet;Julien Bohe

  • Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome.

    Krzysztof Warzocha;Patricia Ribeiro;Jacques Bienvenu;Pascal Roy

  • The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration.

    Guillaume Monneret;Marie-Emmanuelle Finck;Fabienne Venet;Anne-Lise Debard

  • Procalcitonin as an acute phase marker.

    John Whicher;Jacques Bienvenu;Guillaume Monneret

  • Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma.

    Ewa Lech-Maranda;Lucile Baseggio;Jacques Bienvenu;Carole Charlot

  • Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls

    A.L. de Weck;M.L. Sanz;P.M. Gamboa;W. Aberer

  • Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25- lymphocytes.

    Fabienne Venet;Alexandre Pachot;Anne-Lise Debard;Julien Bohé

  • Regional chemotherapy (with mitomycin C) and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis.

    Gilly Fn;Carry Py;Sayag Ac;Brachet A

  • Aerosol Administration of a Recombinant Adenovirus Expressing CFTR to Cystic Fibrosis Patients: A Phase I Clinical Trial

    Gabriel Bellon;Laurence Michel-Calemard;Danièle Thouvenot;Véronique Jagneaux

  • Human CD4+CD25+ Regulatory T Lymphocytes Inhibit Lipopolysaccharide-Induced Monocyte Survival through a Fas/Fas Ligand-Dependent Mechanism

    Fabienne Venet;Alexandre Pachot;Anne-Lise Debard;Julien Bohe

  • Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia.

    Frédéric Duflo;Richard Debon;Guillaume Monneret;Jacques Bienvenu

  • Lack of specificity of procalcitonin for sepsis diagnosis in premature infants

    Alexandre Lapillonne;Eliane Basson;Guillaume Monneret;Jacques Bienvenu

  • Marked improvement of the basophil activation test by detecting CD203c instead of CD63.

    R. Boumiza;G. Monneret;M.-F. Forissier;J. Savoye

  • Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients.

    K Warzocha;G Salles;J Bienvenu;Y Bastion

  • Monitoring of basophil activation using CD63 and CCR3 in allergy to muscle relaxant drugs.

    Guillaume Monneret;Yves Benoit;Anne Lise Debard;Marie C. Gutowski

  • Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective study

    Carole Ferraro-Peyret;Fabienne Coury;Jacques G Tebib;Jacques Bienvenu

Frequent Co-Authors

Guillaume Monneret
Guillaume Monneret Hôpital Édouard-Herriot
Gilles Salles
Gilles Salles Memorial Sloan Kettering Cancer Center
Bertrand Coiffier
Bertrand Coiffier Centre Hospitalier Lyon Sud
Thierry Walzer
Thierry Walzer Claude Bernard University Lyon 1
Pierre Rougé
Pierre Rougé Paul Sabatier University
Fabienne Venet
Fabienne Venet Claude Bernard University Lyon 1
Annick Barre
Annick Barre Paul Sabatier University
Pascal Demoly
Pascal Demoly University of Montpellier
Hubert Vidal
Hubert Vidal Claude Bernard University Lyon 1
Tadeusz Robak
Tadeusz Robak Medical University of Lodz

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse healthcare careers, many of which can be enhanced through specialized nursing degrees. For those interested in mental health, the cheapest online pmhnp programs provide affordable routes to becoming a Psychiatric Mental Health Nurse Practitioner, which complements immunology through the study of neuroimmune interactions.

For advanced practice nurses, understanding how much do dnps make is crucial when considering further education. Doctor of Nursing Practice (DNP) roles often command competitive salaries, reflecting the high level of expertise and responsibility required.

Nurses aiming to specialize further can explore acnp programs, which focus on acute and critical care settings. These programs are particularly relevant for those interested in immunology-related complications in critically ill patients.

Additionally, accelerated pathways, such as the accelerated rn to np programs, offer an efficient route for registered nurses to become nurse practitioners, allowing quicker integration of immunological expertise into patient care roles.

Best Scientists Citing Jacques Bienvenu

Trending Scientists

Recently Published Articles